Cumberland Pharmaceuticals (CPIX) Change in Receivables (2010 - 2026)

Cumberland Pharmaceuticals has disclosed Change in Receivables across 17 years of filings, most recently posting -$2.7 million for Q1 2026.

• Change in Receivables for Q1 2026 came in at -$2.7 million, down 121.07% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.8 million (up 1221.02% YoY), and the FY2025 annual result was $5.2 million, up 169.82% from the prior year.
• Change in Receivables came in at -$2.7 million for Q1 2026 at Cumberland Pharmaceuticals, down from $6.5 million in the prior quarter.
• In the past five years, Change in Receivables ranged from a high of $7.8 million in Q1 2022 to a low of -$2.7 million in Q1 2026.
• The 5-year median for Change in Receivables is -$171014.0 (2025), against an average of $424381.9.
• Across the five-year window, Change in Receivables soared 4421.45% in 2022 and slumped 666.56% in 2024, its largest moves.
• Cumberland Pharmaceuticals' Change in Receivables stood at -$2.1 million in 2022, then dropped by 21.54% to -$2.5 million in 2023, then soared by 115.54% to $390841.0 in 2024, then surged by 1566.71% to $6.5 million in 2025, then slumped by 141.18% to -$2.7 million in 2026.
• The last three Change in Receivables figures came in at -$2.7 million (Q1 2026), $6.5 million (Q4 2025), and $113691.0 (Q3 2025), per Business Quant data.